Theresa I Shireman
Biographic Data
| ID | 186118 |
|---|---|
| NAME | Theresa I Shireman |
| GIVEN NAMES | Theresa I |
| FAMILY NAME | Shireman |
| SIGNATURE | SHIREMAN T I |
| AFFILIATIONS | Brown University |
| ORCID | 0000-0001-6846-8783 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Characterizing disparities in the HIV care continuum among U.S. transgender and cisgender Medicare beneficiaries, 2008–2017
Although HIV is more prevalent among transgender and gender-diverse individuals than cisgender people, a dearth of research has compared the HIV-related care engagement of these populations. Using 2008-2017 Medicare data, we identified TGD (trans feminine and non-binary [TFN], trans masculine and non-binary [TMN], unclassified gender) and cisgender (male, female) beneficiaries with HIV and explored within and between gender group differences in t…
Cardiovascular Health at the Intersection of Race and Gender in Medicare Fee for Service
This cross-sectional study found that Asian and Pacific Islander, Black, and Hispanic TGD beneficiaries had a high prevalence of cardiovascular-related conditions and had an elevated prevalence of several conditions, attributable to the intersection of gender, race, and ethnicity. Medicare should use the tools at its disposal to support the health of TGD beneficiaries
Understanding Provider Treatment Approaches for the Provision of Gender-Affirming Hormones in the Current US Political Climate
Transgender people’s access to gender-affirming hormone therapy (GAHT) is under attack in the United States. In 2024, we interviewed US providers about how they prescribe GAHT. In accordance with informed consent models, providers reported that they reviewed patients’ medical history, social supports, and comorbidities; prescribed GAHT formulations that aligned with patients’ goals; monitored health regularly; and maintained open communication wi…
Impact of a Pharmacy Copayment Increase on Medication Use in the Military Health System
BACKGROUND: We analyzed the impact of a copayment increase instituted February 1, 2018 for persons covered by the retail or mail order Military Health System (MHS) pharmacy benefit. METHODS: We compared medication use in 2 cohorts in the 12 months before and after the copayment increase: MHS beneficiaries between 18 and 64 years old (MHS cohort), and MHS beneficiaries older than or equal to 65 years old with Medicare (Medicare cohort). Subjects w…
The Association Between Moderate and Serious Mental Health Distress and General Health Services Utilization Among Chinese, Filipino, Japanese, Korean, and Vietnamese Adults in California
Use of Antiretroviral Therapy for a US Medicaid Enrolled Pediatric Cohort with HIV
Racial Disparities in Medicaid Home and Community-Based Service Utilization among White, Black, and Hispanic Adults with Multiple Sclerosis
Racial Disparities in Medicaid Home and Community-Based Service Utilization among White, Black, and Hispanic Adults with Multiple Sclerosis
Use of Antiretroviral Therapy for a US Medicaid Enrolled Pediatric Cohort with HIV
The Association Between Moderate and Serious Mental Health Distress and General Health Services Utilization Among Chinese, Filipino, Japanese, Korean, and Vietnamese Adults in California
Characterizing disparities in the HIV care continuum among U.S. transgender and cisgender Medicare beneficiaries, 2008–2017
Although HIV is more prevalent among transgender and gender-diverse individuals than cisgender people, a dearth of research has compared the HIV-related care engagement of these populations. Using 2008-2017 Medicare data, we identified TGD (trans feminine and non-binary [TFN], trans masculine and non-binary [TMN], unclassified gender) and cisgender (male, female) beneficiaries with HIV and explored within and between gender group differences in t…
Cardiovascular Health at the Intersection of Race and Gender in Medicare Fee for Service
This cross-sectional study found that Asian and Pacific Islander, Black, and Hispanic TGD beneficiaries had a high prevalence of cardiovascular-related conditions and had an elevated prevalence of several conditions, attributable to the intersection of gender, race, and ethnicity. Medicare should use the tools at its disposal to support the health of TGD beneficiaries
Understanding Provider Treatment Approaches for the Provision of Gender-Affirming Hormones in the Current US Political Climate
Transgender people’s access to gender-affirming hormone therapy (GAHT) is under attack in the United States. In 2024, we interviewed US providers about how they prescribe GAHT. In accordance with informed consent models, providers reported that they reviewed patients’ medical history, social supports, and comorbidities; prescribed GAHT formulations that aligned with patients’ goals; monitored health regularly; and maintained open communication wi…
Impact of a Pharmacy Copayment Increase on Medication Use in the Military Health System
BACKGROUND: We analyzed the impact of a copayment increase instituted February 1, 2018 for persons covered by the retail or mail order Military Health System (MHS) pharmacy benefit. METHODS: We compared medication use in 2 cohorts in the 12 months before and after the copayment increase: MHS beneficiaries between 18 and 64 years old (MHS cohort), and MHS beneficiaries older than or equal to 65 years old with Medicare (Medicare cohort). Subjects w…
Medicine (7 works) · Health care (6 works) · Gerontology (4 works) · Family medicine (3 works) · Political science (3 works) · Psychology (3 works) · Public health (3 works) · Business (2 works) · Cohort (2 works) · Economic growth (2 works)